Contents
Download PDF
pdf Download XML
394 Views
121 Downloads
Share this article
Research Article | Volume 13 Issue:2 (, 2023) | Pages 254 - 257
Mycobacterium w, New Hope to Sepsis Patients: Initial Experience from Single center
Under a Creative Commons license
Open Access
DOI : 10.5083/ejcm
Published
April 20, 2023
Abstract

Background: Mycobacterium wis an immunomodulatorthat evokes antigen-specific cell-mediated immunity and its use has been evaluated in patients with sepsis, where it resulted in improved outcome.  Methods: We collected data in ten adult patientswith suspected gram-negative sepsis admitted inthe intensive care unit. Injection Mw 0.3 ml was administered intradermal per day for three consecutive days alongwith continuation of standard care. Results: We observed clinical improvement and a significant decrease in TLC and SOFA Score on day 7 after Mw administration. Also, Mw was not associated with any local or systemic adverse effects. Conclusion: The use of Mw was safe and effective in patients with sepsis, though larger randomized trials are required to establish its role.

Keywords
Recommended Articles
Research Article
Assessment of Nutritional Risk Using Nutric Score and Outcomes in Mechanically Ventilated Patients
Published: 15/09/2025
Download PDF
Research Article
Prevalence of Pulmonary Hypertension in Patients with Interstitial Lung Disease: A Cross-Sectional Echocardiographic Study
...
Published: 15/09/2024
Download PDF
Research Article
A study of Alvarado score and USG in Diagnosis of Acute Appendicitis at Tertiary Hospital in Central India.
...
Published: 17/09/2025
Download PDF
Research Article
Point-of-Care Ultrasound versus Auscultation for Confirmation of Endotracheal Tube Placement: A Double-Blinded Prospective Study
...
Published: 17/09/2025
Download PDF
Chat on WhatsApp
Copyright © EJCM Publisher. All Rights Reserved.